Author:
Yang Juan,Liang Meng-yuan,Li Yu,Zhang Hao,Li Wei,Lv Jing,Dong Li-ping,Jin Jing-song,Yang Cheng,Zhang Qing-hong,Long Li,Zou Rong,Gao Yi,Song Dan,Pan Chun-qin,Yao Ying,Zhan Xiao-lin,Wang Xiao-hui
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Eriksson D, Goldsmith D, Teitsson S, et al. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia. BMC Nephrol, 2016,17(1):1–10
2. Hoshino J, Muenz D, Zee J, et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3–5 nondialysis CKD. J Ren Nutr, 2020,30(5):404–414
3. Thorp ML, Johnson ES, Yang X, et al. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology, 2009,14(2):240–246
4. National Institute of Diabetes and Digestive and Kidney Diseases. Anemia in Chronic Kidney Disease ∣ NIDDK [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. 2019. Available from: https://www.mddk.nih.gov/health-information/kidney-disease/anemia
5. Suzuki M, Hada Y, Akaishi M, et al. Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease. Int Heart J, 2012,53(4):238–243